SCHEMBL874583

SCHEMBL874583

NS(=O)(=O)c1ccccc1C(=O)NC1CCCCC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.66
RAB9A P51151 2/20 0.66
ALDH1A1 P00352 2/20 0.66
LMNA P02545 2/20 0.66
HPGD P15428 2/20 0.66
KDM4E B2RXH2 1/20 0.66
HTT P42858 1/20 0.66
CA2 P00918 10/20 0.61
CA9 Q16790 10/20 0.61
CA1 P00915 9/20 0.61
CA12 O43570 9/20 0.61
CA6 P23280 9/20 0.61
CA7 P43166 9/20 0.61
CA13 Q8N1Q1 9/20 0.61
CA4 P22748 8/20 0.61
CA5A P35218 8/20 0.61
CA14 Q9ULX7 8/20 0.61
CA5B Q9Y2D0 8/20 0.61
CA3 P07451 1/20 0.61
MEN1 O00255 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30876857 1.00 NPC1 (0.66) NPC1RAB9AALDH1A1LMNAHPGD
SCHEMBL25302470 0.98 NPC1 (0.63) NPC1RAB9AALDH1A1LMNAHPGD
SCHEMBL11440121 0.85 ALDH1A1 (0.61) NPC1RAB9AALDH1A1LMNAHPGD
SCHEMBL11500322 0.84 ALDH1A1 (0.60) NPC1RAB9AALDH1A1LMNAHPGD
SCHEMBL30666379 0.81 ALDH1A1 (0.77) NPC1RAB9AALDH1A1LMNAHPGD
SCHEMBL14614940 0.80 ALDH1A1 (1.00) NPC1RAB9AALDH1A1LMNAHPGD
SCHEMBL18041117 0.78 ALDH1A1 (0.69) NPC1RAB9AALDH1A1LMNAHPGD
SCHEMBL29229446 0.78 ALDH1A1 (0.69) NPC1RAB9AALDH1A1LMNAHPGD
SCHEMBL2154833 0.78 ALDH1A1 (0.69) NPC1RAB9AALDH1A1LMNAHPGD
SCHEMBL3456445 0.78 ALDH1A1 (0.73) NPC1RAB9AALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018078657-A1 PROCESS FOR PREPARATION OF GLIPIZIDE J.B. CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2018-05-03 WO disclosed
WO-2014074668-A1 MODULATORS OF GPR119 AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2014-05-15 WO disclosed
EP-2619198-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2013-07-31 EP disclosed
WO-2013055910-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2013-04-18 WO disclosed
EP-2556056-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2013-02-13 EP disclosed
WO-2012170702-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2012-12-13 WO disclosed
WO-2012145361-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2012-10-26 WO disclosed
WO-2012145604-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2012-10-26 WO disclosed
WO-2012135570-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2012-10-04 WO disclosed
WO-2012040279-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2012-03-29 WO disclosed
WO-2011127051-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2011-10-13 WO disclosed
EP-1587535-A2 TITLE OF THE INVENTION N-CYCLOHEXYLAMINOCARBONYL BENZENESULFONAMIDE DERIVATIVES Merck & Co., Inc. (US) 2005-10-26 EP disclosed
WO-2004066963-A2 N-CYCLOHEXYLAMINOCARBONYL BENZENESULFONAMIDE DERIVATIVES MERCK & CO., INC. (US) 2004-08-12 WO disclosed